Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa-Induced Dyskinesia”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT04435431
What this trial is testing

A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 155
Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Not applicableStudy completedNCT02200887
What this trial is testing

Sleep Homeostasis in Parkinson's Disease

Who this might be right for
Parkinson Disease
Salvatore Galati 48
Testing effectiveness (Phase 2)Study completedNCT01491932
What this trial is testing

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 129
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT03162874
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

Who this might be right for
Parkinson Disease
Prexton Therapeutics 157
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Early research (Phase 1)UnknownNCT06021756
What this trial is testing

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

Who this might be right for
Levodopa-Induced DyskinesiaParkinson's Disease
University of Arizona 9
Early research (Phase 1)Ended earlyNCT02589340
What this trial is testing

Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Parkinson's DiseaseDyskinesiasMovement Disorders
Oregon Health and Science University 6
Testing effectiveness (Phase 2)UnknownNCT02439125
What this trial is testing

Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Who this might be right for
Parkinson's DiseaseDyskinesia
Amarantus BioScience Holdings, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01937078
What this trial is testing

Famotidine for Levodopa-induced Dyskinesia in PD

Who this might be right for
Dyskinesia
University Health Network, Toronto 7
Testing effectiveness (Phase 2)Temporarily pausedNCT04912115
What this trial is testing

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiasMovement DisordersCentral Nervous System Diseases+2 more
PharmaTher Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00582673
What this trial is testing

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

Who this might be right for
Parkinson's Disease
Novartis 31
Not applicableUnknownNCT04173845
What this trial is testing

Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia

Who this might be right for
Levodopa-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03368170
What this trial is testing

Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 75
Testing effectiveness (Phase 2)WithdrawnNCT03331848
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)

Who this might be right for
Parkinson Disease
Prexton Therapeutics
Not applicableUnknownNCT05752240
What this trial is testing

Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias

Who this might be right for
Parkinson Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Load More Results